News Focus
News Focus
Followers 35
Posts 3996
Boards Moderated 0
Alias Born 11/17/2013

Re: sage007 post# 819986

Tuesday, 03/31/2026 2:11:55 PM

Tuesday, March 31, 2026 2:11:55 PM

Post# of 824037

Post that too, don’t expect huge improvement in the price. There isn’t short squeeze etc happening. As a matter of fact, even after approval, the MMs and hedgies will keep the price suppressed. Until the stock is uplisted and out of OTC, I am afraid nothing really good is likely to happen.


I strongly disagree with parts of your post and your conclusion in particular. I agree that after the uplist there will be less (no) ability to cap the share price at will. But there will definitely be a difference after approval on the OTC as well. Now there are simply no buyers. After the approval there will be many more buyers willing to chase the prize with the nod of approval from the UK. This will make the job of capping the stock much harder and more importantly more expensive and many shorts will not chase a losing short and cover. It will do very well on the OTC despite the shots and yes, do yet better once off the OTC. About the short squeeze, The jury is still out on that one, but no one claims there is a squeeze now. That is silly. But after the MHRA approval, that remains to be seen - It could be something beautiful, or not. You are setting the value of the MAA approval far too short.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News